Reply - 05/02/16
Doi : 10.1016/j.jaci.2015.09.044
Yvonne J. Huang, MD a 
, Joseph R. Arron, MD, PhD b, Homer Boushey, MD c
, Joseph R. Arron, MD, PhD b, Homer Boushey, MD c a Division of Pulmonary/Critical Care Medicine, University of Michigan Health System, Ann Arbor, Mich
b Genentech Inc, South San Francisco, Calif
c Division of Pulmonary/Critical Care Medicine, University of California San Francisco, Calif
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: Y. J. Huang has received a grant from the National Institutes of Health. J. R. Arron is employed by Genentech, Inc and has stock/stock options with The Roche Group. H. Boushey has received grants from the National Institutes of Health/National Heart, Lung, and Blood Institute, GlaxoSmithKline, and Genentech, and has received personal fees from Merck, Genentech, Johnson & Johnson, AAIFNC, Sam Sills Lecture: “Breathe California,” and the McGraw-Hill Companies. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 137 - N° 2
P. 648-649 - février 2016 Retour au numéro
Article précédent
- Potential roles of disordered airway microbiota in patients with severe asthma
- Zongxin Ling, Xia Liu, Yiwen Cheng, Lanjuan Li
- Correction
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?